Loading viewer...
investor_presentation
Format: PDF investor_presentation
Synlait Milk Limited's 2017 strategic update highlights key achievements including ASX dual listing completion, approval to export lactoferrin to the U.S., and NPAT growth to $38.2m. The company raised $97.6m in capital, acquired NZDC to double canning capacity, and secured a five-year infant formula supply agreement with New Hope Nutritionals.
Fusion Pharmaceuticals Corporate Presentation 2023
investor_presentationinvestor_presentation
37 Pages
Fusion Pharmaceuticals
investor_presentation
Dril-Quip
report
investor_presentation
AFT Pharmaceuticals